17 episodes

There's a scientific breakthrough in your medicine cabinet. But how did it get there?
 
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
 
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
 
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.

Making Medicine Incubate Coalition

    • Health & Fitness
    • 5.0 • 14 Ratings

There's a scientific breakthrough in your medicine cabinet. But how did it get there?
 
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
 
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
 
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.

    Understanding Health Equity w/ Dr. Jerome Adams

    Understanding Health Equity w/ Dr. Jerome Adams

    Everyone wants to make healthy choices. But we don't always have an opportunity to make healthy choices. 
    In today’s episode, we speak with Dr. Jerome Adams, Executive Director of Health Equity Initiatives at Purdue University and the 20th Surgeon General of the United States, about the need for proactive accessible health care, the economic burden of inaccessible healthcare, and why people need to know you care, before they care about what you know

    As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting!
    To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

    Addressing The Overlooked AMR Problem w/ Dr. Henry Skinner

    Addressing The Overlooked AMR Problem w/ Dr. Henry Skinner

    Investors are logical people. They invest in medicines that they expect will give them a return.
    Right now, there’s far too little investment in developing new antibiotics. The pipeline of treatment is thin, but the need is greater than ever.
    Enter the AMR Action Fund.
    Hear our conversation with Dr. Henry Skinner, Chief Executive Officer at AMR Action Fund about:
    The increasing cost of AMR and policy challenges
    How to build the pipeline to reach the new antibiotics we need to save millions
    Leveraging healthcare innovation for AMR before it’s too late
    AMR Action Fund’s first two investments and future outlook 


    More information about Henry and today’s topics:
    LinkedIn Profile: http://www.linkedin.com/in/henryskinner/
    Company Website: https://www.amractionfund.com/ 


    As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting!
    To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

    • 42 min
    Pro-Patient Reforms: The Outlook for 2022

    Pro-Patient Reforms: The Outlook for 2022

    We’ll be the first to say that the healthcare system is broken, especially in patient access complexity.
    However, we see three areas where we can execute actionable change for patients in 2022: intellectual property, mergers and acquisitions, and the FDA’s reauthorization.
    In this episode, Coalition Manager and podcast host Ashlyn Roberts interviews John Stanford, Executive Director at Incubate Coalition, about opportunities for pro-patient reform.
    Join us as we discuss:
    A level set of what’s been happening in Washington lately
    Why drug pricing issues are still evergreen
    3 areas for improvement: IP, M&A, and PDUFA
    Shifting the narrative about pro-patient reforms



    As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting!
    To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.
    Listening on a desktop & can’t see the links? Just search for Making Medicine in your favorite podcast player.

    • 17 min
    How Better Data Fosters Health Equity w/ Kirsten Axelsen

    How Better Data Fosters Health Equity w/ Kirsten Axelsen

    If we want data and clinical trials that meaningfully represent the population of people who take the drug, we’ll need to do more than just issue guides.
    In this episode, we interview returning guest Kirsten Axelsen,Senior Advisor for Charles River Associates, about making medicine more accessible to lower income people and creating a more equitable health system with better data.
    Join us as we discuss:
    The detrimental effects of price controls on early life stages of drug development
    Why a price control on one is a price control on all
    The deep concerns about health disparity and equity
    How data can address racism, ageism, and poverty in health systems
    2022 as the year of the non-COVID vaccine



    Check out these resources we mentioned:
    Report referenced at 1:16 here and here.
    Build Back Better Act 



    As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting!
    To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.
    Listening on a desktop & can’t see the links? Just search for Making Medicine in your favorite podcast player.

    • 26 min
    Winning the Drug Development Relay Race w/ Johannes Fruehauf

    Winning the Drug Development Relay Race w/ Johannes Fruehauf

    Drug development is a relay race because you pass the baton to the next runner who will take it to the next level. You are proud to have made it onto the stairs at the end of the race not as an individual but as a huge team of experts of subsequent talents.
    In this episode we interview Johannes Fruehauf, Founder and CEO at LabCentral/BioLabs, about how the relay race metaphor shapes our understanding of drug development and why we need knowledgeable capital to forge ahead.
    Join us as we discuss:
    Solving challenges that face scaling entrepreneurs
    The stages of the drug development relay race
    Investing in a drug development ecosystem that diversifies talent
    The need for investors who understand pharmaceutical startup proposals  


    As we continue this journey together, we want to hear from you, the listener. Email John@incubatecoalition.org or Ashlyn@incubatecoalition.org what’s top of mind, what story you want to hear, or what you find interesting!
    To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.
    Listening on a desktop & can’t see the links? Just search for Making Medicine in your favorite podcast player.

    • 33 min
    New Modalities: The Future of Drug Development w/ Jean-Francois Formela

    New Modalities: The Future of Drug Development w/ Jean-Francois Formela

    Drug policy debate today is like a wetland. It’s the heart of the ecosystem that has to be preserved at all costs — or else we lose the wetlands, the shore, everything.
    In this episode, we interview Jean-Francois Formela, Partner at Atlas Venture, about what brought him to Washington and his views on the government’s role in drug development.
    Join us as we discuss:
    Where are we going in drug development
    The role of new modalities
    Investor goals: great science, great company, good return
    A future in which governments enable the biopharmaceutical community to cure disease



    To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.
    Listening on a desktop & can’t see the links? Just search for Making Medicine in your favorite podcast player.

    • 35 min

Customer Reviews

5.0 out of 5
14 Ratings

14 Ratings

Noel LT ,

Super informative

WOW this is a sexy pod

Top Podcasts In Health & Fitness

Scicomm Media
Jay Shetty
Aubrey Gordon & Michael Hobbes
Lewis Howes
Rob Dial and Kast Media
Sal Di Stefano, Adam Schafer, Justin Andrews, Doug Egge

You Might Also Like

STAT
BioCentury
The New York Times
Morningstar